ATOSSA THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.475 USD | -1.67% |
|
+11.11% | +70.45% |
Chart calendar Atossa Therapeutics, Inc.
1a36021a3eb4fcb7fa7e.c_teudBbW9X7Boz22AUqMsnyGQ7O3hz9bw45Y-39KDw.H6Ev_78cDeHKNcTAnTQabbuIX12RinqqFjpxLJ_Fan8pvzXw5Q4J5a1IzQ~c99af935a2ee154d46e0a61c47c4bb7f
Upcoming events on Atossa Therapeutics, Inc.
Past events on Atossa Therapeutics, Inc.
| 2024-04-17 09:00 am | Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference |
| 2024-04-09 12:00 pm | American Association for Cancer Research Meeting - Abstract Number: CT205 |
| 2024-04-01 04:00 pm | Q4 2023 Earnings Release |
| 2024-02-20 09:00 am | Winter Wrap-Up MicroCap Rodeo Virtual Investor Conference |
| 2023-11-13 09:00 am | Q3 2023 Earnings Release |
| 2023-09-28 09:10 am | Cantor Global Healthcare Conference |
| 2023-08-14 12:31 pm | Q2 2023 Earnings Release |
| 2023-08-14 09:00 am | Q2 2023 Earnings Call |
| 2023-07-11 10:00 am | Virtual Investor Summer Spotlight Series |
| 2023-06-21 11:30 am | Maxim Group Virtual Healthcare Conference |
| 2023-06-04 09:00 am | American Society of Clinical Oncology Conference - Abstract No.: TPS633 Poster Bd# 454a |
| 2023-05-15 09:10 am | Q1 2023 Earnings Release |
| 2023-05-04 11:00 am | Investor Meeting - Fireside Chat |
| 2023-05-04 09:00 am | Annual General Meeting |
| 2023-03-23 01:00 pm | Sidoti Spring Small-Cap Conference |
| 2023-03-22 04:05 pm | Q4 2022 Earnings Release |
| 2022-11-07 04:00 pm | Q3 2022 Earnings Release |
| 2022-09-11 | H.C. Wainwright Global Investment Conference |
| 2022-08-14 | Interim 2022 Earnings Release (Projected) |
| 2022-05-24 12:30 pm | H.C. Wainwright Global Life Sciences Investment Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -17,3 -18,3 5.65% | -14,6 -15,0 2.82% | -20,5 -21,7 5.27% | -27,7 -27,8 0.5% | -31,4 -31,2 -0.56% | -36,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -17,2 -18,3 5.65% | -17,8 -15,0 -18.89% | -20,6 -21,8 5.27% | -27,0 -27,8 2.99% | -30,1 -30,2 0.19% | -35,3 |
|
Net income Million USD | Released Forecast Spread | -17,2 -18,3 5.65% | -17,8 -15,0 -18.89% | -20,6 -21,8 5.27% | -27,0 -27,8 2.99% | -30,1 -30,2 0.19% | -35,3 |
|
EPS USD | Released Forecast Spread | -2,03 -2,03 0% | -1,97 -1,21 -63.49% | -0,18 -0,19 2.7% | -0,21 -0,22 4.55% | -0,24 -0,24 0% | -0,27 |
| Announcement Date | 26/03/20 | 31/03/21 | 28/02/22 | 22/03/23 | 01/04/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -4,83 -5,97 19.06% | -4,75 -7,00 32.19% | -6,60 -5,99 -10.06% | -8,21 -6,96 -17.85% | -8,14 -8,31 2.04% | -7,10 -8,00 11.28% | -7,79 -7,73 -0.86% | -7,47 -8,36 10.68% | -9,02 -8,09 -11.47% | -8,50 | -8,80 | -9,10 | -9,47 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,83 -5,97 18.99% | -4,79 -7,00 31.63% | -6,67 -5,99 -11.35% | -8,01 -6,96 -15.06% | -7,49 -8,31 9.83% | -6,28 -8,00 21.49% | -9,83 -7,73 -27.22% | -6,23 -8,36 25.5% | -7,75 -7,79 0.48% | -8,13 | -8,47 | -8,80 | -9,23 |
|
Net income Million USD | Released Forecast Spread | -4,83 -5,97 18.99% | -4,79 -7,00 31.63% | -6,67 -5,99 -11.35% | -8,01 -6,96 -15.06% | -7,49 -8,31 9.83% | -6,28 -8,00 21.49% | -9,83 -7,73 -27.22% | -6,23 -8,36 25.5% | -7,75 -7,79 0.48% | -8,13 | -8,47 | -8,80 | -9,23 |
|
EPS USD | Released Forecast Spread | -0,04 -0,05 11.11% | -0,04 -0,06 33.33% | -0,05 -0,05 0% | -0,06 -0,06 -9.09% | -0,06 -0,07 7.69% | -0,05 -0,06 16.67% | -0,08 -0,06 -33.33% | -0,05 -0,07 25% | -0,06 -0,06 0% | -0,06 | -0,06 | -0,07 | -0,07 |
| Announcement Date | 28/02/22 | 09/05/22 | 08/08/22 | 07/11/22 | 22/03/23 | 15/05/23 | 14/08/23 | 13/11/23 | 01/04/24 | - | - | - | - |
More events
Past sector events for Atossa Therapeutics, Inc.
| Today | PHARMARON BEIJING CO., LTD.: Q1 2024 Earnings Release |
| Today | HANGZHOU TIGERMED CONSULTING CO., LTD: Q1 2024 Earnings Release |
| Today | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
| 2024-04-24 04:15 pm | ICON PUBLIC LIMITED COMPANY: Q1 2024 Earnings Release |
| 2024-04-24 10:21 am | SYNGENE INTERNATIONAL LIMITED: Q4 2024 Earnings Release |
| 2024-04-24 07:06 am | CUREVAC N.V.: Q4 2023 Earnings Release |
| 2024-04-24 01:45 am | ADDLIFE AB: Q1 2024 Earnings Release |
| 2024-04-24 01:00 am | EVOTEC SE: Q4 2023 Earnings Release |
| 2024-04-23 | SINO BIOLOGICAL,INC.: Q4 2023 Earnings Release |
| 2024-04-23 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ATOS Stock
- Calendar Atossa Therapeutics, Inc.
